Posted by john on June 28th, 2006 — in Aldara Top News
A rapid (24-hour) test is now available to identify neuropathic strains of equine herpesvirus-1 (EHV-1). This means in the event of an outbreak of herpesvirus, or if a horse has neurologic signs of undetermined origin, a veterinarian can take a blood sample or nasal swab and know by the next day whether the horse tests […]
No Comments »
Posted by john on June 26th, 2006 — in Aldara Top News
A systematic review of research studies has concluded that there is not yet enough evidence to indicate that anal Papanicolau (Pap) smears should be used routinely to detect pre-cancerous cells in people with HIV. The review’s results were published in the 15th July edition of Clinical Infectious Diseases.
Anal cancer is more common in gay men […]
No Comments »
Posted by john on June 20th, 2006 — in Aldara Top News
A Vaccine For Herpes Could Be On The Market By Next Year.. If It’s Found To Prevent The Sexually Transmitted Disease.
The Vaccine Only Works In Women.. With About 20-Thousand Women Across The U-S.. Taking Part In The Study.
Sarah Mackay/Nurse Practitioner
” I Think A Lot Of Our Subjects Come In And People Are Motivated To Come […]
No Comments »
Posted by john on June 14th, 2006 — in Aldara Top News
SAN CARLOS, CA, USA | Jun 13, 2006 | NeurogesX, Inc., a privately held specialty pharmaceutical company, today announced that it has completed enrollment in its 400-patient Phase 3 trial of its investigational drug Transacin(TM) (NGX-4010) in patients suffering from postherpetic neuralgia (PHN). Transacin is NeurogesX’s novel high-concentration trans-capsaicin dermal patch. The randomized, double blind, […]
No Comments »
Posted by john on June 11th, 2006 — in Aldara Top News
Q. I’m encouraged by the performance of my shares of 3M Co. but wonder how long this will last. What’s your take?
–K.T., via the Internet
A. This Dow Jones industrial average component, best known for Scotch tape and Post-it notes, is increasingly taking an international view.
A strengthening global economy could make that a smart move.
Operating […]
No Comments »
Posted by john on June 8th, 2006 — in Aldara Top News
When 3M Co. said in early April that it wanted to sell its underperforming pharmaceutical division, the news was just the prescription to continue a run-up in 3M’s stock price.
Finding out what the division is actually worth, though, will take longer. And identifying a buyer and closing the deal is likely to take many months, […]
No Comments »
Posted by john on June 5th, 2006 — in Aldara Top News
Red, flaky spots, moles that bleed — most people ignore these symptoms to avoid surgery.
New advances in treatment mean patients don’t have to go under the knife to be skin-cancer free.
More Info
Dr. Joe Giancola
Southwest Skin Specialists
11130 N. Tatum Blvd.
(602) 494-1817
“Before I ever lived here as a kid, I was always in the sun […]
No Comments »
Posted by john on June 3rd, 2006 — in Aldara Top News
According to the results of a study published in the Journal of the American Academy of Dermatology, Aldara™ (imiquimod 5% cream) effectively treats squamous cell carcinoma in situ of the skin.
More than one million new cases of skin cancer are diagnosed each year in the U.S., making it the most commonly diagnosed type of cancer.
Skin […]
No Comments »
Posted by john on June 1st, 2006 — in Aldara Top News
Researchers from the United Kingdom have reported that Aldara cream (imiquimod 5%) was effective for treating cutaneous squamous cell carcinoma in situ. The details of this report appeared in the June 2006 issue of the Journal of the American Academy of Dermatology .[1]
Previous studies have shown that Aldara was highly effective in treating actinic keratosis, […]
No Comments »